Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas
2007

Mitochondrial DNA mutations in parathyroid adenomas

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Jessica Costa-Guda, Takehiko Tokura, Sanford I. Roth, Andrew Arnold

Primary Institution: Center for Molecular Medicine, University of Connecticut School of Medicine

Hypothesis

Mitochondrial DNA mutations may contribute to the benign tumorigenesis of parathyroid adenomas.

Conclusion

Mitochondrial DNA mutations may confer a selective advantage and contribute to the molecular pathogenesis of parathyroid adenomas.

Supporting Evidence

  • Twenty-seven somatic mutations were identified in 15 of 30 parathyroid adenomas studied.
  • No somatic mutations were observed in the hyperplastic parathyroid glands.
  • Statistically significant differences in mutation prevalence were found between oxyphil and chief cell adenomas.

Takeaway

This study looked at DNA changes in tumors from the parathyroid glands and found that certain mutations might help these tumors grow.

Methodology

The entire mitochondrial genome was sequenced from 30 parathyroid adenomas and compared with normal controls.

Limitations

The study did not address the potential pathogenetic significance of certain mitochondrial deletions.

Participant Demographics

Patients who underwent parathyroidectomy for primary hyperparathyroidism, with no known history of head or neck irradiation.

Statistical Information

P-Value

0.02

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6823-7-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication